← BACK TO JOURNAL
ADVANCED SKIN

What Morpheus8 Body Does — and What It Doesn’t

Dr. Raneiro
6 min read
What Morpheus8 Body Does — and What It Doesn’t

Almost everything written about this treatment falls into one of two camps. Either it’s a miracle that melts fat and erases cellulite, or it’s dismissed as an expensive way to do nothing. Neither is correct, but the evidence is quite interesting. Here we’ll take a deep dive into the studies involved in how this treatment truly produces visible results.

We perform this treatment and we charge for it. What follows includes the parts that cost us bookings.

What is it actually doing under the skin?

Morpheus8 Body uses the same principle as the facial device — needles delivering radiofrequency energy — but at a depth the face never sees. Up to 7mm, which puts the needle tips through the dermis and into the subcutaneous fat layer.

That’s the entire distinction. On the face we’re treating skin. Here we’re treating skin and the tissue beneath it, and those are different targets requiring different energy.

Two things happen. In the dermis, thermal energy drives collagen remodelling, which is what tightens. Below it, heat is delivered directly into the fat compartment and the fibrous bands running through it.

The same mechanism reads differently depending on where you are treating. On the face, fat loss from RF microneedling is a complication — one of the genuine risks of an over-energetic operator. On the abdomen or the back of the arm, a degree of fat effect is the goal. Same physics, opposite intention, which is why the settings are not interchangeable and why we treat these as separate procedures rather than “Morpheus8, but lower.”

Does it actually reduce fat?

Some. Less than the marketing implies, and measured less rigorously than you’d want.

Alexiades, in Lasers in Surgery and Medicine, treated skin laxity and localised fat deposits above the knee, on the upper arms, and along the bra-line with a single dermal and subcutaneous microneedle RF treatment, following patients at one, three and six months.

Here’s the caveat that matters: outcomes were assessed with five-point Likert scales for global aesthetic improvement, laxity improvement and satisfaction. Those are subjective ratings, not volumetric measurements. Nobody scanned these patients and calculated how many cubic centimetres of fat disappeared.

Fact vs. Fad: This is not liposuction and it is not a weight-loss treatment. We don’t work from a BMI cutoff, because the number wouldn’t tell me what I need to know. What matters is the shape of the problem. A modest deposit sitting under skin that has lost its tone is a good target. A significantly overweight abdomen is not — this is not a fat-loss device and no series of treatments will turn it into one. If a flat abdomen is the goal and there is real volume there, that’s a metabolic conversation, and it’s one we’re glad to have. Just not with this machine.

What about cellulite?

This is where the evidence is genuinely strongest, and it surprised me.

Alexiades, Munavalli, Goldberg and Berube ran a multicentre trial across four treatment centres in Dermatologic Surgery. Fifty patients with Nürnberger-Müller Grade II or III cellulite received a single subcutaneous microneedle RF treatment at 67°C for four seconds.

The methodology is what makes it worth citing. Three dermatologists graded randomised, standardised photographs while blinded to timepoint, at baseline and at one, three and six months. Success was defined by the FDA’s own threshold — at least a one-point improvement in dimple count or undulation severity, confirmed by at least two of the three blinded graders. Their conclusion was that subcutaneous microneedle RF is safe and effective for long-term treatment of Grade II and III cellulite in a single session.

Blinded graders and a pre-specified regulatory endpoint put this well above the typical energy-device study.

Now the limits, because they’re real. Fifty patients. No sham-treated control group. Six months of follow-up, not years. And “at least one point of improvement” is a meaningful bar but a modest one — it is not the same as clearance.

The mechanism makes sense of why it works at all. Cellulite isn’t fat; it’s fibrous septae tethering the skin down to deeper tissue, and fat pushing up between them. Heat delivered at the level of those septae addresses the actual anatomy. That’s also why devices working only at the skin surface disappoint.

I’d frame the realistic outcome as visible improvement in dimpling, not elimination. Anyone promising smooth thighs is selling you something the literature doesn’t support.

And stretch marks?

Real improvement, and I can give you the number.

Adatto and colleagues, in the Journal of Cosmetic Dermatology, treated 17 subjects across 67 treatment zones with four fractional RF sessions at four-week intervals, then measured with 3D photography at 16 weeks. Average reduction in striae volume: 19.1%. Redness fell 14.3%, pigmentation 11.2%.

Nineteen percent is a genuine, objectively measured improvement. It is also not disappearance, and I’d rather you have that number in your head than a before-and-after photograph taken in flattering light.

A 2024 systematic review and meta-analysis of microneedling for striae distensae found a statistically significant benefit specifically in the microneedle radiofrequency subgroup. So the effect holds up across the pooled literature, not just one study.

One practical note: older, white, mature stretch marks respond less than newer red or purple ones. If yours are recent, that’s an argument for treating sooner.

Where can we treat, and who does it?

Abdomen, thighs, inner thighs, and the back of the upper arms.

The inner thigh and the posterior arm are the two areas patients most often can’t fix with training, because the problem there is skin quality and septae rather than muscle. They’re also where a modest improvement is most visible in clothing.

At this practice, Morpheus8 Body is performed by our physicians. Facial Morpheus8 is performed by a physician or our advanced practice nurse. Either way, you choose your provider when you book, and the provider you choose is the one who performs your treatment — not a colleague, not whoever is free that day.

The body treatment sits with the physicians because the needles are going into the subcutaneous plane at energies where the margin for error is smaller than it is on the face.

On how many sessions: minimum two, and after that it’s a moving target. We look at what your tissue actually did rather than working from a package sold up front. If I think another round will add something meaningful, I’ll say so. If you’re happy with where you’ve landed and I don’t think I can improve on it, I’ll tell you that instead — which is the less profitable answer and usually the right one.

Expect topical numbing beforehand, and most people describe the treatment as pressure and warmth rather than sharp pain. Plan for a few days of redness and some swelling afterward. Collagen remodelling is slow: results build over about three months and continue to develop out to six.

What won’t it do?

It isn’t liposuction, and it won’t do what liposuction does.

It isn’t a tummy tuck. If you have genuine skin excess — an apron of loose tissue after major weight loss or pregnancy — that is a surgical problem, and no amount of radiofrequency will substitute. I’d rather tell you that at the consultation than after you’ve paid for a series.

It isn’t a weight-loss treatment, and it isn’t a substitute for one.

And it isn’t a single-session miracle, despite two of the trials above using single treatments. Those studies were designed to test whether one treatment could produce measurable change, which is a scientific question, not a treatment plan.

What it is: a reasonable option for localised laxity, moderate cellulite, and stretch marks, with better published evidence behind it than most things in this category — and honest limits that any clinic should be willing to say out loud before taking your money.

 

 

 

 

 

References

Alexiades M, Munavalli G, Goldberg D, Berube D. Prospective multicenter clinical trial of a temperature-controlled subcutaneous microneedle fractional bipolar radiofrequency system for the treatment of cellulite. Dermatologic Surgery. 2018;44(10):1262–1271.

Alexiades M. Single treatment protocol with microneedle fractional radiofrequency for treatment of body skin laxity and fat deposits. Lasers in Surgery and Medicine. 2021. doi:10.1002/lsm.23397

Adatto MA, et al. Clinical evaluation of the efficacy of fractional radiofrequency for the treatment and reduction of stretch marks: a prospective study. Journal of Cosmetic Dermatology. 2023. doi:10.1111/jocd.15463

Microneedling therapy for striae distensae: systematic review and meta-analysis. Aesthetic Plastic Surgery. 2024. PMID: 38509316

BOOK NOW